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An in vitro model for Pelger-Huët anomaly

Stable knockdown of lamin B receptor in HL-60 cells
Ada L. Olins,1 Aurélie Ernst,2,† Monika Zwerger,3,‡ Harald Herrmann3 and Donald E. Olins1,*
Department of Biology; Bowdoin College; Brunswick, ME USA; 2Division of Molecular Genetics; 3Functional Architecture of the Cell; German Cancer Research Center;
Heidelberg, Germany

1

Current addresses: †Karolinska Institute; CMB; Stockholm, Sweden; Brigham and Women’s Hospital/Harvard Medical School; Cambridge, MA USA

Key words: lamin B receptor, nuclear structure, Pelger-Huët anomaly, neutrophil, macrophage
Abbreviations: LBR, lamin B receptor; RA, retinoic acid; ECL, enhanced chemiluminescence; GFP, HL-60/S4 cell subline which
has a stable green fluorescent protein expressing gene; S4, HL-60/S4 cell subline; sh1, HL-60/S4 cell subline with a stable LBR
knockdown; ELCS, envelope-limited chromatin sheets; TPA, phorbol ester; PHA, Pelger-Huët anomaly; NE, nuclear envelope;
ER, endoplasmic reticulum

The principal human blood granulocyte (neutrophil) possesses a lobulated and deformable nucleus, important to
facilitate rapid egress from blood vessels as these cells migrate to sites of bacterial or fungal infection. This unusual nuclear
shape is a product of elevated levels of an integral membrane protein of the nuclear envelope lamin B receptor (LBR) and
of decreased amounts of lamin A/C. In humans, a genetic deficiency of LBR produces Pelger-Huët anomaly, resulting in
blood neutrophils that exhibit hypolobulated nuclei with redistributed heterochromatin. Structural changes in nuclear
architecture occur during granulopoiesis within bone marrow. The exact mechanisms of this nuclear shape change and
of heterochromatin redistribution remain largely unknown. As a tool to facilitate analysis of these mechanisms, a stable
LBR knockdown subline of HL-60 cells was established. During in vitro granulopoiesis induced with retinoic acid, the LBR
knockdown cells retain an ovoid shaped nucleus with reduced levels of lamin A/C; while, the parent cells develop highly
lobulated nuclei. In contrast, macrophage forms induced in LBR knockdown cells by in vitro treatment with phorbol ester
were indistinguishable from the parent cells, judged by both nuclear shape and attached cell morphology. The capability
of differentiation of LBR knockdown HL-60 cells should facilitate a detailed analysis of the molecular relationship between
LBR levels, granulocyte nuclear shape and heterochromatin distribution.

Introduction
Lamin B receptor (LBR), encoded by a single gene, is an integral
membrane protein of the nuclear envelope (NE), interacting
with lamin B and heterochromatin and functioning to regulate interphase nuclear shape and heterochromatin distribution
within myeloid cells.1,2 Genetic deficiency of LBR in humans
results in Pelger-Huët anomaly (PHA, MIM 169400),3 characterized by neutrophil nuclear hypolobulation and redistribution of peripheral heterochromatin towards the center of the
nucleus. A more severe manifestation of human LBR deficiency
is observed in the lethal fetal HEM/Greenberg skeletal dysplasia, in which cholesterol metabolism is profoundly affected.4 A
homologous LBR deficiency in mouse results in Ichthyosis (ic),
changing the normally ring-shaped neutrophil nucleus to ovoid
shape with central clustering of the pericentric heterochromatin
and associated with an increased death of homozygous mutant
fetuses.5 Considerable knowledge about the nuclear changes

in heterozygous (+/ic) and homozygous (ic/ic) Ichthyosis was
achieved by the creation of immortalized bone marrow cells
from the mouse mutants, which can be differentiated to granulocyte form in vitro by the addition of retinoic acid (RA).6,7 As
yet, no similar immortalized human PHA bone marrow cells
have been created to allow the study of nuclear changes during
RA induced granulocyte differentiation in vitro. However, the
established human acute myelocytic cell line (HL-60) 8 (and a
more recent subline HL-60/S4,9) can be differentiated with RA
in vitro from ovoid to lobulated nuclear shape, exhibiting an
increase in cellular levels of LBR and a decrease in lamin A/C
and vimentin content.10,11 Consequently, the authors of this
paper conceived that an LBR knockdown within HL-60 cells
might mimic human PHA, furnishing a convenient model cell
line for the study of myeloid differentiation in the absence of
LBR and for elucidating mechanisms underlying the acquisition of aberrant nuclear architecture. We describe creation and
characterization of a stable LBR knockdown subline derived
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Figure 1. Immunoblotting of the three undifferentiated HL-60 cell sublines with anti-LBR, lamins, β-tubulin and actin. Cell sublines: S4, parent;
GFP, infected with GFP expressing vector; sh1, short hairpin knockdown
of LBR.

from HL-60/S4 cells infected with a lentiviral construct encoding a short-hairpin RNA targeting human LBR.
Results
Formation of a subline of HL-60/S4 with a stable LBR knockdown. Employing lentiviral vectors, we have established two
stable cell sublines of HL-60/S4: one encoding a short hairpin
RNA targeting human LBR; the other, expressing GFP. Both
of these sublines exhibited vigorous growth and healthy microscopic appearance. The LBR knockdown subline is denoted
“sh1”; the GFP expressing subline, denoted “GFP”; the parent
subline, denoted “S4”. Total cell extracts of the undifferentiated S4, GFP and sh1 sublines were run on a 4–20% gradient
SDS-PAGE and analyzed by immunoblotting with antibodies
against LBR, lamins A, B1 and B2, β-tubulin and actin (Fig.
1). The ECL (enhanced chemiluminescence) images clearly
show a massive reduction of LBR in the sh1 cells, compared
to either the S4 or GFP cells (which displayed similar levels of
LBR). There were no comparable changes in the levels of the
lamins, β-tubulin or actin in these three undifferentiated cell
sublines.
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A comparison of calculated doubling times for the undifferentiated S4 and sh1 sublines (based upon cell titers during
exponential growth) indicated that these two sublines grew
at comparable rates: S4 doubled in ~16 hrs; sh1, in ~17 hrs.
Cell cycle analysis was also performed on these two undifferentiated sublines in their exponential growth phases, following
ethanol fixation, RNAse digestion and propidium iodide staining. Analysis of S4 revealed: G1 ~36%; S ~50%: G2 ~12%. In
contrast, sh1 cells appeared to spend somewhat more time in S
phase, exhibiting: G1 ~23%; S ~65%; G2 ~10%. Despite these
small differences in doubling time and cell cycle parameters,
these cell sublines grow robustly with minimal indication of
cell death during the exponential phase.
Granulocyte differentiation with retinoic acid. When
HL-60/S4 cells are exposed to 1 μM RA for 4 days, at least
~80% of the cells exhibit nuclear lobulation and formation
of nuclear envelope-limited chromatin sheets (ELCS).10,12 In
parallel to this nuclear change from ovoid to lobulated shape,
nuclear envelope and cytoskeletal protein changes have been
documented, employing both immunofluorescence and immunoblotting methods:11,13,14 the protein expression level of LBR
increases; the low levels of lamin A/C decrease further; vimentin undergoes a massive reduction; β-actin increases slightly.
Many other proteins exhibited little or no change in amount or
cellular location; e.g., lamin B2; lamin B1 (which may decrease
slightly); LAP2β; emerin; HP1α; SUN2; α-tubulin. We sought
to determine how the knockdown of LBR in the sh1 subline
might influence these previously described phenotypic effects
of RA induced granulocyte differentiation.
An immunofluorescent comparison of S4 and sh1 cells, with
and without RA treatment and stained for LBR is presented in
Figure 2. All image data in this figure were collected with identical microscope conditions on a Zeiss 710 confocal microscope,
allowing semi-quantitative comparison of antibody staining
intensities. Only selected images (Fig. 2 bottom row, sh1* cells)
were subjected to image processing (see below). Undifferentiated
S4 nuclei are mostly ovoid or indented with clear LBR localization in the NE. After 4 days of RA treatment, the differentiated nuclei exhibit lobulation and indentation, with bright
anti-LBR staining of ELCS, as previously described.10-12,14,15
Overall, the differentiated NE reveals a stronger staining by
anti-LBR, than that seen within undifferentiated S4 cells, as
previously described14,15 and in agreement with immunoblot
data (see below). By contrast, the sh1 cells present negligible
staining with anti-LBR (although a faint increase is seen after
RA treatment). The bottom row (Fig. 2) presents the same
sh1 images as in the middle row, processed with Photoshop to
facilitate visualization of nuclear shape. DAPI staining of DNA
demonstrates that undifferentiated and RA treated sh1 cells
primarily possess ovoid shaped nuclei. This apparent lack of
nuclear shape change within sh1 cells, following 4 days of RA
treatment, was confirmed by thin section electron microscopy
(Fig. 3). These images convincingly demonstrate that the vast
majority of S4 cells display nuclear lobulation and ELCS following 4 days of RA treatment, as shown previously;10 but the
sh1 cell nuclei remain primarily ovoid in shape.
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An extensive immunoblotting
comparison of S4 and sh1 cells,
with and without RA treatment, is
presented in Fig. 4 and summarized
in Table 1. The major conclusions
are as follows: (1) LBR is severely
reduced in the sh1 cells, exhibiting a trace amount in undifferentiated cells which increases after RA
treatment; (2) Lamin A/C, which
is normally quite low in undifferentiated S4 cells (and may be
slightly reduced in sh1 cells), is
reduced further after RA in S4 and
sh1 cells; (3) Lamin B1 is relatively
unchanged comparing S4 and sh1
(±RA); (4) Lamin B2 is strong and
unchanged comparing S4 and sh1
(±RA); (5) Vimentin is weak in
undifferentiated S4 and sh1 cells
(perhaps slightly stronger in sh1
cells), virtually disappearing after
RA treatment in both sublines; (6)
SUN1 is very weak in undifferentiFigure 2. Confocal immunofluorescent staining of undifferentiated and RA treated S4 and sh1 cells
ated cells (perhaps slightly stronger
with anti-LBR. All data was collected with identical microscope settings. Cell states: 0, undifferentiated
cells, leftmost two columns; RA, differentiated for four days, rightmost two columns. Top row: S4, parent
in sh1 cells), virtually disappearing
HL-60/S4 cell subline. Middle row: sh1, HL-60/S4 cell subline with a stable LBR knockdown. Bottom row:
like vimentin after RA; (7) SUN2
sh1*, same images as the middle row after image processing. Magnification bar: 10 μm.
appears to display a slight increase
in both S4 and sh1 after RA; (8)
Emerin, α-tubulin, HP1α, HP1β and HP1γ are present and display a characteristic mixture of solitary attached cells with
essentially unchanged, comparing S4 and sh1 ± RA. These con- long cytoplasmic extensions interspersed with clusters of cells.
clusions are largely consistent with previous immunoblot com- Figure 6 presents an immunostaining experiment with S4 and
parisons of S4 cells (±RA).11,14
sh1 cells treated with TPA (4 days), methanol and acetone fixed
Macrophage differentiation with phorbol ester.
When HL-60 cells, which normally grow as suspension
cultures, are treated with the phorbol ester TPA, they
quickly attach, cease to divide and differentiate into
macrophage cells.10,11,14,16,17 The nuclei in HL-60/S4
cells remain ovoid in the macrophage state and there is
a striking increase in lamin A/C, vimentin, plectin and
nesprin 1 giant proteins.11,14 We inquired whether LBR
knockdown in sh1 cells results in obvious perturbations
of TPA induced macrophage differentiation. Figure 5
presents the results of Wright-Giemsa staining of S4
and sh1 cells, undifferentiated or treated with TPA for
3 days. The undifferentiated cells were cytocentrifuged
onto coverslips, flattening the cells prior to staining; the
TPA treated cells grew attached to coverslips and were,
consequently, less flattened prior to staining. Even so, it
is clear that the S4 and sh1 cells look very much alike,
before or after TPA treatment. The TPA treated cells
Figure 3. Thin section electron microscopy of undifferentiated and RA treated S4 and sh1 cells. Note the appearance of
a lobulated nucleus and chromatin sheets (ELCS) in the RA
treated S4 cells and their absence in the RA treated sh1 cells.
Magnification bar: 1 μm.
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the levels of SUN2 and β-actin remain largely unchanged in
the same experiment. In summary, we showed that the near
absence of LBR in sh1 cells has only a minimal effect on the
differentiation of HL-60/S4 cells to a macrophage form following exposure to TPA.
Discussion

Figure 4. Immunoblotting of total cell extracts from undifferentiated
and RA treated S4 and sh1 cells. Cell states: 0, undifferentiated cells; RA,
differentiated for four days. The Ponceau S stained membrane demonstrates that the protein loads were well matched. LBR exhibits a small
amount of degradation.

and reacted with anti-LBR and anti-lamin B2. It is clear that
there is much more LBR in the S4 cells, than the sh1 cells,
with localization in both the cytoplasm and the NE. The nuclei
are ovoid in shape in both cell sublines, with comparable NE
staining by anti-lamin B2. Immunoblotting experiments were
also performed upon extracts of S4 and sh1 (±) TPA (Fig. 7).
Comparable to previous experiments on S4 cells,14 these experiments demonstrate that both S4 and sh1 cells reveal an increased
synthesis of lamin A and plectin following treatment with TPA;

www.landesbioscience.com

The present study demonstrates that LBR knockdown in the
sh1 subline of HL-60/S4 cells results in one obvious phenotypic consequence: maintenance of an ovoid nuclear shape in
sh1 cells induced to granulocytic differentiation with RA. This
phenotype is in sharp contrast to S4 cells (and GFP cells) where
RA treatment consistently leads to nuclear lobulation and the
formation of ELCS.1,2,10,12 The absence of nuclear lobulation in
granulocytic forms of sh1 cells is in agreement with the observation of ovoid nuclei within granulocytes of human PHA 3
and of mouse Ichthyosis,5 both genetic conditions resulting in
significantly reduced levels of LBR. This LBR dosage effect is
nicely demonstrated in a recent study,18 where the average number of human granulocyte nuclear lobes correlates with the level
of cellular LBR, encompassing 0 to 3 copies of the LBR gene.
Aside from this one significant morphologic characteristic, the
changes (or lack of changes) in the levels of various NE and
cytoskeletal proteins, previously documented within granulocytic S4 cells,11,14 appear unperturbed by the absence of LBR in
sh1 cells (Fig. 4 and Table 1). Likewise, the morphological and
immunochemical changes observed when S4 cells are differentiated into macrophages by treatment with TPA, remain largely
unaltered by the absence of LBR in sh1 cells (Figs. 5–7).
The mechanism relating LBR content to granulocyte nuclear
lobulation remains obscure. The primary hypothesis involves
a structural interpretation of LBR 2 residing within the inner
nuclear membrane and interacting with peripheral heterochromatin and the lamina, which is more deformable in granulocytes due to reduced levels of lamin A/C. It is also speculated
that LBR, which possesses sterol reductase activity, might be
involved with nuclear membrane growth. Furthermore, LBR is
one of the first NE proteins to bind to chromosomes during
post-mitotic nuclear reformation, which may be an important
time during the cell cycle for determining interphase nuclear
architecture. The influence of LBR dosage on nuclear shape,
although most dramatic in granulocytic cells, has been detected
in other cell types. Lymphoblastoid cells from normal individuals frequently display irregular or indented nuclear shape;
whereas those from individuals with PHA show a more ovoid
nuclear shape.3 In addition, U2OS cells that overexpress LBR
frequently exhibit irregular and indented nuclear shape, not
seen in wildtype or LBR knockdown cells.19
It is anticipated that the development of a stable LBR knockdown HL-60 subline, capable of multiple paths of differentiation in vitro, will contribute to a deeper understanding of the
structural and functional role of LBR within myeloid cells.
These cells should permit one to ask whether LBR plays a pivotal role in establishing or stabilizing certain routes of differentiation in pluripotent hematopoietic cells.
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Materials and Methods

Table 1. Relative changes in the levels* of various proteins during RA
treatment of S4 and sh1 cells

S4
sh1
Cell culture. HL-60/S4 was cultivated in RPMI 1640 medium
Protein
0
RA
0
RA
plus 10% heated fetal calf serum and pen/strep as described
11
earlier. RA and TPA stocks were added to cells as described
LBR
+
++
~0
+/earlier.11 The stable viral infected GFP and sh1 sublines were
Lamin A/C
+
~0
+
+/maintained in the same RPMI 1640 medium plus 1 μg/ml puroLamin B1
+
+
+
+
mycin. During RA or TPA differentiation of the GFP and sh1
Lamin B2
+
+
+
+
sublines, puromycin was not present within the media.
Emerin
+
+
+
+
Measuring cell growth parameters. Growth curves for the
SUN1
+/~0
+/~0
S4 and sh1 cells were obtained using a Vi-CellXR Cell Viability
SUN2
+
+
+
+
Analyzer (Beckman Coulter, Brea CA). Cells were initiated at
5
10 cells/ml and viable cells measured on a daily basis (4 days).
Vimentin
+
~0
+
~0
Viability was routinely >95%. Cell cycle measurements were
+
+
+
+
α-Tubulin
made at the Flow Cytometry Core Facility (German Cancer
+
+
+
+
HP1α
Research Center), with data acquisition on a FACSCalibur
+
+
+
+
HP1β
(BD Biosciences, San Jose CA). Cells were fixed overnight with
+
+
+
+
HP1γ
70% ethanol (-20oC), washed in PBS, digested with RNase
*
o
The
relative
protein
levels
were
evaluated
from
immunoblots.
Each
(50 μg/ml, 30 min, 37 C) and stained with Propidium Iodide
antibody reaction was evaluated under the same ECL exposure condi(50 μg/ml, 10 min) before analysis.
tions on a single blot. Notation: ++, very strong; +, medium to strong;
LBR silencing. Lentiviral vectors were produced by co+/-, trace reaction; ~0, negligible reaction.
transfection of HEK293T cells with the psPAX2, pMD2.G
and pLKO.1 constructs (MISSION TRC-Hs 1.0).22
Transfections were carried out using TransIT (Mirus Bio
Corporation, Madison, WI). Virus was harvested 72 hours
after transfection. Infections of HL60/S4 cells were carried out in the presence of 8 μg/ml of polybrene. Viruscontaining supernatant was removed after 24 hours. shRNA
construct MISSION NM_002296.2-548s1c1 was used for
LBR silencing and pLKO.1-puro CMV GFP was used as a
control (both Sigma-Aldrich, St. Louis MO). Initial selection with puromycin was performed in 12 well plates, which
included untreated and “mock” (polybrene only) samples.
Immunoblotting and immunostaining. The numerous antibodies employed in this study have been described
earlier.7,11,14,15 These antibodies include: (1) guinea pig antiLBR, emerin and plectin; (2) rabbit anti-SUN1 and SUN2;
(3) mouse monoclonal anti-lamins A/C, B1, B2 and antivimentin, α-tubulin, β-actin, HP1α, HP1β and HP1γ.
In addition, for Figure 1, the following antibodies were
employed: anti-actin, pan-isoforms (20-33; A5060, Sigma
Aldrich, St. Louis MO) and β-tubulin (ab6046, Abcam,
Cambridge MA). Total cell extracts were prepared in
1 x Laemmli sample buffer as described previously.11,14
Immunoblotting was performed by SDS-PAGE in 4–20%
BioRad gradient gels, followed by transfer to Millipore
Immobilon-P membranes and an ECL reaction captured
Figure 5. Wright-Giemsa stained preparations of S4 and sh1 cells following
with X-ray film.11,14 During immunostaining, undifferentidifferentiation to macrophage form. Cell states: 0, undifferentiated; TPA,
ated or RA treated cells were allowed to settle onto fresh polymacrophage differentiation by TPA treatment for three days. Sublines: S4, top
row; sh1, bottom row. Magnification bar: 10 μm.
lysine-coated slides in a moist chamber (30 min, RT), fixed
o
with 4% paraformaldehyde/PBS or with -20 C methanol/
acetone, washed, permeabilized (0.1% Triton X-100/PBS)
and blocked with 5% normal goat serum/PBS, using conditions objective. Images were deconvolved using the built in SoftWoRx
previously published.15 For some imaging experiments (Fig. 6), software. For others (Fig. 2), images were obtained on a Zeiss
data were collected on a DeltaVision Core microscope (Applied 710 confocal microscope using a 63x objective. Image collecPrecision Inc., Issaquah WA) using either a 40x, 60x or a 100x tion parameters were kept constant allowing a semi-quantitative
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comparison of the levels of anti-LBR staining in the
different samples. The data was collected by Dr.
Sven Poppelreuther at the Carl Zeiss MicroImaging
Application Center, Im Neuenheimer Feld 581,
69120 Heidelberg. Except for Figure 2 (bottom
row), no image processing was applied to the confocal data; Photoshop was employed to permit clearer
visualization of nuclear shape (bottom row).
Electron microscopy. The suspension cells
HL-60/S4 and HL-60/sh1, undifferentiated or
treated with RA for 4 days, were centrifuged into a
pellet, fixed with glutaraldehyde and OsO4, washed,
dehydrated, embedded in epon, thin sectioned and
stained, as described in previous publications.10,23
Images were collected on a Philips 400 electron
microscope at the German Cancer Research Center
(Heidelberg).
Figure 6. Deconvolved immunostaining images of S4 and sh1 cells after differentiation to macrophage with TPA. The left column of images is a merge of staining with
anti-lamin B2 (green) and DAPI (blue); middle column, merge of anti-LBR (red) and
DAPI (blue). The right column (DIC) includes differential interference contrast images
of the same fields, more clearly indicating the cytoplasm and cell membranes with
protrusions. Magnification bar: 10 μm.
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